Mark E. Silverman

2.2k total citations
71 papers, 1.5k citations indexed

About

Mark E. Silverman is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and History. According to data from OpenAlex, Mark E. Silverman has authored 71 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Cardiology and Cardiovascular Medicine, 24 papers in Surgery and 15 papers in History. Recurrent topics in Mark E. Silverman's work include Medical History and Innovations (12 papers), Cardiovascular Syncope and Autonomic Disorders (10 papers) and Neurology and Historical Studies (8 papers). Mark E. Silverman is often cited by papers focused on Medical History and Innovations (12 papers), Cardiovascular Syncope and Autonomic Disorders (10 papers) and Neurology and Historical Studies (8 papers). Mark E. Silverman collaborates with scholars based in United States, Canada and United Kingdom. Mark E. Silverman's co-authors include Samuel J. DeMaio, J. Willis Hurst, Charles B. Upshaw, Ibrahim R. Hanna, Spencer B. King, Charles S Bryan, William Osler, John N. Oshinski, Roderic I. Pettigrew and Charles F. Wooley and has published in prestigious journals such as Circulation, Annals of Internal Medicine and Gastroenterology.

In The Last Decade

Mark E. Silverman

68 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark E. Silverman United States 21 979 530 324 273 145 71 1.5k
Joseph Abbott United States 27 1.6k 1.6× 531 1.0× 117 0.4× 399 1.5× 153 1.1× 93 2.3k
Irvin F. Goldenberg United States 22 1.6k 1.6× 982 1.9× 205 0.6× 287 1.1× 202 1.4× 55 2.1k
Jerold S. Shinbane United States 18 1.3k 1.4× 344 0.6× 230 0.7× 324 1.2× 118 0.8× 52 1.8k
Brendan Madden United Kingdom 23 421 0.4× 556 1.0× 913 2.8× 168 0.6× 104 0.7× 98 1.6k
Thomas Lavergne France 23 2.8k 2.9× 350 0.7× 217 0.7× 145 0.5× 223 1.5× 78 3.1k
Girish M. Nair Canada 28 3.0k 3.1× 685 1.3× 330 1.0× 178 0.7× 144 1.0× 110 3.5k
Christian Knackstedt Netherlands 23 1.4k 1.4× 259 0.5× 110 0.3× 451 1.7× 91 0.6× 105 1.8k
Christof Kolb Germany 25 1.6k 1.7× 426 0.8× 97 0.3× 128 0.5× 68 0.5× 120 2.1k
John W. Petersen United States 20 998 1.0× 414 0.8× 117 0.4× 604 2.2× 101 0.7× 81 1.5k
Joan Castell‐Conesa Spain 19 698 0.7× 490 0.9× 140 0.4× 797 2.9× 454 3.1× 128 1.6k

Countries citing papers authored by Mark E. Silverman

Since Specialization
Citations

This map shows the geographic impact of Mark E. Silverman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Silverman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Silverman more than expected).

Fields of papers citing papers by Mark E. Silverman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Silverman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Silverman. The network helps show where Mark E. Silverman may publish in the future.

Co-authorship network of co-authors of Mark E. Silverman

This figure shows the co-authorship network connecting the top 25 collaborators of Mark E. Silverman. A scholar is included among the top collaborators of Mark E. Silverman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark E. Silverman. Mark E. Silverman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Silverman, Mark E., et al.. (2009). Claudius Galen of Pergamum: Authority of Medieval Medicine. Clinical Cardiology. 32(11). E82–3. 12 indexed citations
2.
Upshaw, Charles B. & Mark E. Silverman. (2009). Woldemar Mobitz: Early Twentieth Century Expert on Atrioventricular Block. Clinical Cardiology. 32(11). E75–7. 1 indexed citations
3.
Silverman, Mark E., et al.. (2009). Spencer Bidwell King III, MD. Clinical Cardiology. 32(11). E80–1. 1 indexed citations
4.
Silverman, Mark E. & Charles B. Upshaw. (2008). Walter Holbrook Gaskell. Clinical Cardiology. 31(7). 340–341. 5 indexed citations
5.
Silverman, Mark E. & Charles B. Upshaw. (2007). Extracardiac Manifestations of Infective Endocarditis and Their Historical Descriptions. The American Journal of Cardiology. 100(12). 1802–1807. 30 indexed citations
6.
Silverman, Mark E.. (2005). Hearts are too good to die. The history of defibrillation.. PubMed. 68(2). 17–22. 1 indexed citations
7.
Hanna, Ibrahim R. & Mark E. Silverman. (2002). A history of cardiac auscultation and some of its contributors. The American Journal of Cardiology. 90(3). 259–267. 75 indexed citations
8.
Upshaw, Charles B. & Mark E. Silverman. (2001). Alfred Lewis Galabin and the first human documentation of atrioventricular block. The American Journal of Cardiology. 88(5). 547–550. 2 indexed citations
9.
Mendel, David & Mark E. Silverman. (2001). William evans. Clinical Cardiology. 24(6). 487–489.
10.
Upshaw, Charles B. & Mark E. Silverman. (2000). John hay: Discoverer of type ii atrioventricular block. Clinical Cardiology. 23(11). 869–871. 6 indexed citations
11.
Silverman, Mark E.. (1999). A view from the millennium: the practice of cardiology circa 1950 and thereafter. Journal of the American College of Cardiology. 33(5). 1141–1151. 9 indexed citations
12.
Silverman, Mark E.. (1996). Etienne‐Jules Marey: 19th Century cardiovascular physiologist and inventor of cinematography. Clinical Cardiology. 19(4). 339–341. 14 indexed citations
13.
Silverman, Mark E., et al.. (1996). Diagnosis of Cardiac Sarcoidosis Aided by MRI. CHEST Journal. 110(2). 562–565. 38 indexed citations
14.
Silverman, Mark E.. (1993). James Bovell: a remarkable 19th-century Canadian physician and the forgotten mentor of William Osler.. PubMed. 148(6). 953–7. 3 indexed citations
15.
Carey, Daniel, J. Willis Hurst, & Mark E. Silverman. (1992). Coronary spasm and cardiac arrest after coronary arteriography in unsuspected thyrotoxicosis. The American Journal of Cardiology. 70(7). 833–834. 12 indexed citations
16.
Silverman, Mark E.. (1991). Andreas vesalius and de humani corporis fabrica. Clinical Cardiology. 14(3). 276–279. 10 indexed citations
17.
Williams, John F., Jeffrey L. Anderson, Rolf M. Gunnar, et al.. (1990). Task Force V: The relation of cardiovascular specialists to industry, institutions and organisations. Journal of the American College of Cardiology. 16(1). 30–36. 1 indexed citations
18.
DeMaio, Samuel J., et al.. (1989). Clinical course and long-term prognosis of spontaneous coronary artery dissection. The American Journal of Cardiology. 64(8). 471–474. 267 indexed citations
19.
Silverman, Mark E., et al.. (1989). Effects of the cholecystokinin receptor antagonist L-364,718 on experimental pancreatitis in mice. Gastroenterology. 96(1). 186–192. 26 indexed citations
20.
Silverman, Mark E., et al.. (1987). Prognosis in survivors of acute myocardial infarction occurring at age 70 years or older. The American Journal of Cardiology. 60(13). 971–975. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026